Skip to main content
HTFL logo

HTFL · Heartflow, Inc.

Track HTFL — free
$48.91 -0.80 (-1.61%) At close · Sep 4
Market Cap
$4.25B
Shares
86.95M

HTFL metrics

64 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$48.91
Market cap
$4.25B

Price action

19 metrics
Price change (1W)
+2.4%
Price change (30D)
+66.6%
Price change (3M)
+74.1%
Price change (6M)
+112.8%
Price change (YTD)
+67.8%
Price change (1Y)
+43.5%
Trailing year
Price change (5Y)
52-week high
$50.43
52-week low
$20.49
Change from 52-week high
-3.0%
Change from 52-week low
+138.7%
Annualized volatility
80.4%
Beta
1.6
RSI (14D)
73.4
Price vs SMA 50
+44.2%
Price vs SMA 200
+63.4%
Avg volume (3M)
1.82M
Relative volume
0.8
Average dollar volume
$65.76M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
86.95M

Valuation

12 metrics
P / E (TTM)
16.1
Trailing earnings · reciprocal yield 6.2%
PEG ratio
EV / revenue
EV / EBITDA
EV / EBIT
P / sales
20.1×
reciprocal yield 5.0%
P / book
15.2
reciprocal yield 6.6%
FCF yield
-1.4%
TTM · current market cap
Buyback yield
P / FCF
P / operating cash flow
Earnings yield
-2.8%

Historical valuation

8 metrics
P / E historical average (3Y)
P / E historical average (5Y)
EV / revenue historical average (3Y)
EV / revenue historical average (5Y)
EV / EBIT historical average (3Y)
EV / EBIT historical average (5Y)
EV / EBITDA historical average (3Y)
EV / EBITDA historical average (5Y)

Dividends & buybacks

7 metrics
Dividend yield
Trailing 12 months
Payout ratio
Shareholder yield
Dividend / share (TTM)
Dividend growth YoY
Dividend growth streak
Last ex-dividend

Earnings calendar

2 metrics
Next earnings
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
80.1%
Operating margin
-37.8%
Trailing 12 months
Net margin
-55.8%
Gross profit (TTM)
$169.83M
Operating profit (TTM)
−$80.25M
Net income (TTM)
−$118.37M
Trailing 12 months
Diluted EPS (TTM)
$3.04
FCF margin
-27.9%
Effective tax rate

Per share

11 metrics
Revenue per diluted share (TTM)
Gross profit per diluted share (TTM)
Operating profit per diluted share (TTM)
EBITDA per diluted share (TTM)
Net income per diluted share (TTM)
Operating cash flow per diluted share (TTM)
Free cash flow per diluted share (TTM)
Capital expenditures per diluted share (TTM)
R&D per diluted share (TTM)
Stock compensation per diluted share (TTM)
Book value per share
$-140.39

Growth

11 metrics
Revenue growth YoY
+47.6%
Year over year
Net income growth YoY
Revenue (TTM)
$212.07M
Trailing 12 months
EPS growth YoY
Shares change YoY
+1,267.9%
Year over year · more shares
Revenue CAGR (3Y)
Revenue CAGR (5Y)
EPS CAGR (3Y)
EPS CAGR (5Y)
FCF CAGR (3Y)
FCF CAGR (5Y)

Quality

14 metrics
Return on equity
-42.3%
Return on assets
-34.4%
Debt / equity
Current ratio
5.1
EBITDA (TTM)
−$74.94M
Free cash flow (TTM)
−$59.18M
Quick ratio
5.1
Interest coverage
Net debt / EBITDA
Return on invested capital
Trailing 12 months
Net cash
$162.55M
Latest balance sheet
Cash & equivalents
$34.36M
Total assets
$344.46M
Total debt

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$52.23M
Capital expenditures (TTM)
$6.95M
R&D (TTM)
$83.84M
SG&A (TTM)
$158.76M
Stock compensation (TTM)
$23.69M
R&D / revenue
39.5%
Stock compensation / revenue
11.2%

Ownership (13F)

3 metrics
13F filers
194
13F filer change QoQ
+25
Institutional ownership
86.2%

Short interest

3 metrics
Short interest
7.8%
Latest settlement · 3.9 days to cover
Days to cover
3.9d
Short-squeeze score
62 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$8.99M
Insider-sentiment score

Risk flags

1 metrics
Going concern
Key facts CIK 1464521 CUSIP 42238D107 13F (30d) 135 filings 135 filers Visit website Investor relations